Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. On January 28, 2026, Advanced Biomed Inc., a Nevada Corporation (the “Company”), entered into a securities purchase
Unregistered Sales of Equity Securities. The information included in Item 1.01 of this Current Report is incorporated by reference into this Item 3.02 of this C
Financial Statement and Exhibits. Exhibit No. Description 10.1 Form of Securities Purchase Agreement 104 Cover Page Interactive Data File (embedded within the I